Compare · HEXO vs NVCN
HEXO vs NVCN
Side-by-side comparison of HEXO Corp. (HEXO) and Neovasc Inc. (NVCN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HEXO and NVCN operate in Pharmaceuticals and Biotechnology (Health Care), so they compete in similar markets.
- HEXO is the larger of the two at $176.3M, about 6.3x NVCN ($27.8M).
- HEXO has more recent analyst coverage (11 ratings vs 0 for NVCN).
- Company
- HEXO Corp.
- Neovasc Inc.
- Price
- $0.70+3.98%
- $30.03+1.35%
- Market cap
- $176.3M
- $27.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Pharmaceuticals and Biotechnology
- Pharmaceuticals and Biotechnology
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 0
- 0
- Recent ratings
- 11
- 0
HEXO Corp.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.
Neovasc Inc.
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Latest HEXO
- Cash Flow Chronicles: Analyst Dissects Canadian Cannabis Balance Sheets, Market Trends Vs. The US
- EXCLUSIVE: Key Insights And 4 Predictions On Cannabis Sector Equity Research For 2024
- SEC Form 15-12G filed by HEXO Corp.
- 'North Carolina Senate Approves Medical Marijuana Regulatory Appointment As House Leader Says 'Heavy-Handed' Tactics Not Helping Legalization's Fate' - Marijuana Moment
- 'Major Marijuana Industry Players Launch Super Pac To Advance Cannabis Reform As 2024 Election Heats Up' - Marijuana Moment
- 'Schumer Touts Marijuana Banking Bill As Bipartisan Priority, And Republican Sponsor Is Optimistic As Long As Measure Isn't Expanded' -Marijuana Moment Report
- Tilray's HEXO Acquisition Creates Canada's Top Cannabis Company With 44% Market Share Boost
- SEC Form 25-NSE filed by HEXO Corp.
- SEC Form F-10POS filed by HEXO Corp.
- SEC Form F-10POS filed by HEXO Corp.
Latest NVCN
- Volato Announces Changes to Board Composition
- SEC Form EFFECT filed by Neovasc Inc.
- SEC Form 15F-12B filed by Neovasc Inc.
- SEC Form 6-K filed by Neovasc Inc.
- SEC Form 6-K filed by Neovasc Inc.
- SEC Form RW filed by Neovasc Inc.
- SEC Form F-10POS filed by Neovasc Inc.
- SEC Form POS AM filed by Neovasc Inc.
- SEC Form S-8 POS filed by Neovasc Inc.
- SEC Form 25-NSE filed by Neovasc Inc.